Table 1 Age and gender for patients with acromegaly receiving octreotide or lanreotide
All patients | Patients with a 180-day washout period | ||||||
|---|---|---|---|---|---|---|---|
Therapy | Variable | N | Mean | SD | N | Mean | SD |
Octreotide | Age at first injection (yr) | 1127 | 50.6 | 11.1 | 545 | 51.4 | 11.2 |
% of male patients | 1127 | 45.9% | 0.5 | 545 | 48.1% | 0.5 | |
Lanreotide | Age at first injection (yr) | 181 | 45.9 | 11.9 | 118 | 45.7 | 11.7 |
% of male patients | 181 | 45.9% | 0.5 | 118 | 44.9% | 0.5 | |